Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-04-14

FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for amlodipine besylate from Teva Pharmaceuticals, approving a generic version of the drug. This supplemental approv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine besylate (amlodipine besylate)

Snippet

SUPPL AP for AMLODIPINE BESYLATE (AMLODIPINE BESYLATE)